Stocks and Investing
Stocks and Investing
Wed, May 10, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Ng Maintained (BLND) at Strong Buy with Decreased Target to $1.3 on, May 10th, 2023
Michael Ng of Goldman Sachs, Maintained "Blend Labs, Inc." (BLND) at Strong Buy with Decreased Target from $1.5 to $1.3 on, May 10th, 2023.
Michael has made no other calls on BLND in the last 4 months.
There are 2 other peers that have a rating on BLND. Out of the 2 peers that are also analyzing BLND, all agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Joseph Vafi of "Canaccord Genuity" Maintained at Hold with Decreased Target to $2 on, Friday, March 17th, 2023
- Ryan Tomasello of "Keefe, Bruyette & Woods" Maintained at Hold with Increased Target to $1.4 on, Thursday, March 9th, 2023
Contributing Sources